Counterweight Ventures’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88M | Buy |
20,914
+603
| +3% | +$112K | 2.54% | 16 |
|
|
2025
Q1 | $4.26M | Buy |
20,311
+40
| +0.2% | +$8.38K | 3.05% | 8 |
|
|
2024
Q4 | $3.6M | Buy |
20,271
+675
| +3% | +$120K | 2.55% | 16 |
|
|
2024
Q3 | $3.87M | Buy |
19,596
+3,148
| +19% | +$622K | 2.74% | 11 |
|
|
2024
Q2 | $2.82M | Buy |
16,448
+96
| +0.6% | +$16.5K | 2.13% | 18 |
|
|
2024
Q1 | $2.98M | Buy |
16,352
+539
| +3% | +$98.2K | 2.4% | 14 |
|
|
2023
Q4 | $2.45M | Buy |
+15,813
| New | +$2.45M | 2.23% | 18 |
|